SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is experiencing intense market volatility driven by a strategic partnership with NVIDIA to deploy five gigawatts of AI infrastructure and a concurrent NVIDIA warrant agreement, which has overshadowed the company's mixed earnings report. While the community is actively debating the stock's future as an AI infrastructure powerhouse versus the potential for share dilution and the sustainability of the valuation, sentiment remains polarized between those anticipating a major breakout and those questioning the transparency of the earnings release.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to heightened volatility and investor speculation ahead of its upcoming earnings report, as the market debates whether the company's massive revenue backlog and capital-intensive expansion will eventually lead to profitability or if persistent margin pressure and debt levels will continue to trigger post-earnings sell-offs. The community remains sharply divided, with bulls highlighting explosive demand for AI infrastructure and 'neocloud' dominance, while bears point to negative unit economics and a repetitive historical pattern of share price declines following earnings releases.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense investor focus as the community anticipates their upcoming earnings report, with bulls highlighting the company's path to EBITDA profitability and improved unit economics while bears remain skeptical of the housing market environment. Sentiment is polarized, with participants actively debating potential price action as they watch for management's guidance on the company's turnaround progress and future growth strategies.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as the market reacts to the company's decision to cut 14% of its workforce to optimize operations for the AI era while navigating crypto market volatility. Investors are actively debating the impact of these layoffs on profitability alongside the broader sector anticipation surrounding the Clarity Act and ongoing institutional interest in Bitcoin.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors react to a new lawsuit against commercial partner NS Pharma, which challenges the existing distribution agreement and raises concerns over launch preparedness and pricing structures. While the news has triggered volatility and community debate regarding potential launch delays versus the benefit of regaining full control of the drug, many remain bullish on the long-term outlook, viewing the legal dispute as a strategic move to clear the way for a more effective partnership or acquisition ahead of the PDUFA date.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme market volatility ahead of its earnings report, with the community expressing deep frustration over the stock's prolonged downward trend and lack of clear strategic direction from leadership. Investors are actively debating the potential for an OpenAI partnership or acquisition while closely monitoring management's ability to navigate current growth headwinds.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently in focus as investors anticipate its upcoming earnings report, with community sentiment driven by a record-breaking backlog and expanding defense partnerships like the new contract with Anduril. Traders are actively debating the company's trajectory and vertical integration strategy while closely monitoring key technical resistance levels ahead of the expected volatility.

Chip

Chip is currently the subject of intense community debate as holders balance optimism around its AI hardware lending protocol against concerns over insider lock-ups and rapid price volatility. Investors are closely monitoring its performance relative to broader AI sector trends, with many debating whether the current price action represents a consolidation phase or a sustained downtrend.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare stock is facing significant volatility following a weak revenue guide and a major strategic pivot that includes a 20% workforce reduction to focus on an AI-driven operating model. While investors are debating whether the productivity gains from AI can justify the restructuring risks and valuation, the community remains divided between those viewing the pullback as a buying opportunity for a long-term growth compounder and those concerned that the stock remains priced for perfection.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending after receiving a second FDA rejection for its cancer therapy, tabelecleucel, despite the company claiming previous alignment on clinical trial requirements. Community sentiment is deeply divided, with many traders debating the risk of near-term dilution while others discuss the potential for an appeal or an acquisition as the company faces a liquidity crunch.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Misonix has long been at the forefront of ultrasound technology and is a world leader in the design, development, manufacturing, and marketing of ultrasonic surgical devices. Their innovative, ultrasonic platforms for surgical applications include aspirators for the removal of both soft and hard tissue, instruments for laparoscopic cutting and coagulation, devices for wound cleansing and debridement, products for precision bone cutting and sculpting, liposuction instrumentation for improving body aesthetics, and High Intensity Focused Ultrasound (HIFU) systems for the ablation of tumors.

MSON
Misonix Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest MSON News

MSONMisonix Inc.